These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 2422317)

  • 1. Protection of mice from lethal influenza: evidence that defective interfering virus modulates the immune response and not virus multiplication.
    Dimmock NJ; Beck S; McLain L
    J Gen Virol; 1986 May; 67 ( Pt 5)():839-50. PubMed ID: 2422317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of mice from lethal influenza by adoptive transfer of non-neutralizing haemagglutination-inhibiting IgG obtained from the lungs of infected animals treated with defective interfering virus.
    McLain L; Dimmock NJ
    J Gen Virol; 1989 Oct; 70 ( Pt 10)():2615-24. PubMed ID: 2794973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterologous protection of mice from a lethal human H1N1 influenza A virus infection by H3N8 equine defective interfering virus: comparison of defective RNA sequences isolated from the DI inoculum and mouse lung.
    Duhaut SD; Dimmock NJ
    Virology; 1998 Sep; 248(2):241-53. PubMed ID: 9721233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of mice from lethal influenza by defective interfering virus: T cell responses.
    McLain L; Morgan DJ; Dimmock NJ
    J Gen Virol; 1992 Feb; 73 ( Pt 2)():375-81. PubMed ID: 1371542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of three strains of mice against lethal influenza in vivo by defective interfering virus.
    Morgan DJ; McLain L; Dimmock NJ
    Virus Res; 1993 Aug; 29(2):179-83. PubMed ID: 8212859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of putative defective interfering (DI) A/WSN RNAs isolated from the lungs of mice protected from an otherwise lethal respiratory infection with influenza virus A/WSN (H1N1): a subset of the inoculum DI RNAs.
    Noble S; Dimmock NJ
    Virology; 1995 Jun; 210(1):9-19. PubMed ID: 7793084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective interfering type A equine influenza virus (H3N8) protects mice from morbidity and mortality caused by homologous and heterologous subtypes of influenza A virus.
    Noble S; Dimmock NJ
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3485-91. PubMed ID: 7996140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective interfering influenza virus inhibits immunopathological effects of infectious virus in the mouse.
    Morgan DJ; Dimmock NJ
    J Virol; 1992 Feb; 66(2):1188-92. PubMed ID: 1731097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of mice infected with a lethal dose of Semliki Forest virus by defective interfering virus: modulation of virus multiplication.
    Barrett AD; Guest AR; Mackenzie A; Dimmock NJ
    J Gen Virol; 1984 Nov; 65 ( Pt 11)():1909-20. PubMed ID: 6094709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective interfering influenza virus confers only short-lived protection against influenza virus disease: evidence for a role for adaptive immunity in DI virus-mediated protection in vivo.
    Scott PD; Meng B; Marriott AC; Easton AJ; Dimmock NJ
    Vaccine; 2011 Sep; 29(38):6584-91. PubMed ID: 21762748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal-infant transfer of influenza-specific immunity not detectable by haemagglutination inhibition.
    Reuman PD; Kris RM; Ayoub EM; Small PA
    Microbios; 1988; 54(220-221):135-47. PubMed ID: 2846987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interfering vaccine: a novel antiviral that converts a potentially virulent infection into one that is subclinical and immunizing.
    Noble S; McLain L; Dimmock NJ
    Vaccine; 2004 Aug; 22(23-24):3018-25. PubMed ID: 15297051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An influenza haemagglutinin-specific IgG enhances class I MHC-restricted CTL killing in vitro.
    McLain L; Dimmock NJ
    Immunology; 1991 May; 73(1):12-8. PubMed ID: 1646161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloned defective interfering influenza virus protects ferrets from pandemic 2009 influenza A virus and allows protective immunity to be established.
    Dimmock NJ; Dove BK; Scott PD; Meng B; Taylor I; Cheung L; Hallis B; Marriott AC; Carroll MW; Easton AJ
    PLoS One; 2012; 7(12):e49394. PubMed ID: 23251341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective interfering virus protects elderly mice from influenza.
    Scott PD; Meng B; Marriott AC; Easton AJ; Dimmock NJ
    Virol J; 2011 May; 8():212. PubMed ID: 21549019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity.
    Liew FY; Russell SM; Appleyard G; Brand CM; Beale J
    Eur J Immunol; 1984 Apr; 14(4):350-6. PubMed ID: 6609824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift.
    Lambkin R; McLain L; Jones SE; Aldridge SL; Dimmock NJ
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3493-502. PubMed ID: 7527838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cell culture-derived whole-virus H9N2 vaccine induces high titer antibodies against hemagglutinin and neuraminidase and protects mice from severe lung pathology and weight loss after challenge with a highly virulent H9N2 isolate.
    Wodal W; Falkner FG; Kerschbaum A; Gaiswinkler C; Fritz R; Kiermayr S; Portsmouth D; Savidis-Dacho H; Coulibaly S; Piskernik C; Hohenadl C; Howard MK; Kistner O; Barrett PN; Kreil TR
    Vaccine; 2012 Jun; 30(31):4625-31. PubMed ID: 22580355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of resistance to influenza virus infection in animal models.
    Potter CW; McLaren C; Jennings R
    Dev Biol Stand; 1975; 28():307-18. PubMed ID: 1126574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.